TrialReader


Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles

NCT03805243 — Not applicable, Terminated, 1 participants, BioSerenity

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Evaluation of the Signals électrophysiologiques Measured by Intelligent Textiles

RegistryNCT03805243, acronym DATASET
StatusTerminated - Change of products design
PhaseNot applicable
Study typeInterventional; non randomized, single group, masking: none, other
Enrollment1 (Actual)
SponsorBioSerenity (Industry)
ConditionsHealthy
Interventionstest of sensors for somnonaute device, test of sensors for uronaute device, test of sensors for toconaute device, test of sensors for neuronaute device, test of sensors for cardioskin device (Device)
Datesstart 2019-11-29, primary completion 2020-12-21, completion 2020-12-21, first posted 2019-01-15, last updated 2021-11-11
Locations1 site in France

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Healthy All trials of test of sensors for somnonaute device All trials of test of sensors for uronaute device

-Summary

BioSerenity suggests developing innovative solutions, from intelligent clothes which can be used in a hospital environment or at home. These textiles allow, in particular, to measure the biophysiological signals while letting to the participant the freedom pursue its daily activities.

BioSerenity has already developed two wearable wireless and portable medical devices: cardioskin with textile ECG electrods , and the Neuronaute with textile EEG, EMG electrods.

The aim of the study is to test these sensors to optimize their signal to integrate them in future Bioserenity devices like a somnonaute to help diagnosis of sleep disorders, like uronaute to help diagnosis of urination disorders, like toconaute to help monitoring of pregnancy. Others CE-marked sensors developed by others manufacturers will be tested to choose those that will be integrated in the Bioserenity devices.

Expand all sections  ·  Collapse all

+Detailed description

The various alone sensors tested in the clinical trial (sensors of Bioserenity and the other manufacturers), will supply information which will allow to develop future devices. Some of these sensors will then be selected to integrate them.

The tests will be made according to the therapeutic area of the concerned device(plan). There are 5 therapeutic areas:

Cardiovascular (Cardioskin device), neurology ( Neuronaute device), urology ( Uronaute device), obstetrics ( Toconaute device), somnologie (Somnonaute device).

One subject would likely test either one sensor of a device or multiple sensors, either an entire device.

+Arms and interventions

ArmTypeInterventionsDescription
test of sensors for somnonaute deviceExperimentalDevice: test of sensors for somnonaute devicemonitoring with sensors
test of sensors for uronaute deviceExperimentalDevice: test of sensors for uronaute devicemonitoring with sensors
test of sensors for toconaute deviceExperimentalDevice: test of sensors for toconaute devicemonitoring with sensors
test of sensors for cardioskin deviceExperimentalDevice: test of sensors for cardioskin devicemonitoring with sensors
test of sensors for neuronaute deviceExperimentalDevice: test of sensors for neuronaute devicemonitoring with sensors
  • test of sensors for somnonaute device (Device): test of sensors
  • test of sensors for uronaute device (Device): test of sensors
  • test of sensors for toconaute device (Device): test of sensors
  • test of sensors for neuronaute device (Device): test of sensors
  • test of sensors for cardioskin device (Device): test of sensors

+Outcome measures

Primary outcomes

  • Sensor quality validation [24 months]: Signal is considered as of "good quality" " not good quality" regarding criteria of signal patterns : eg amplitude of signal, regularity..

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* women or men >18 years
* affiliation to a social security system

Exclusion Criteria:

* Wounds or wounds on the body and the scalp;
* Refusal of consent, minor
* Not membership to the Social Security
* Participant not capable of following the procedure of use (according to the judgment of the investigator);
* Brain surgery that took place less than a week ago
* Allergy known about the money, the polyamide, the silicone, the synthetic materials;
* Sensory Disorders(Confusions) returning the insensible subject to the pain;
* Motor or mental disorders preventing the subject from expressing his pain;
* Behavioral problems that make the subject excessively agitated or aggressive;
* People with cardio-respiratory problems likely to be aggravated by the slight compression of the thorax;
* Subject equipped with an electrical stimulation device;
* Unsuitable anthropometric Parameters (for the women, the sizes superior to 24 will be excluded and for the men(people) those superior to 34);
* Pregnancy clinically detectable or known for the subject;
* Current(in class) Participation in a clinical trial or participation in a previous clinical trial understanding(including) a period of not past(over) deficiency at the time of this clinical trial.
* Predisposition in the headaches of tension (the compression exercised by the hat(cap) can activate(start) in certain cases a headache);
* Use of the device(plan) within the framework of a resuscitation or of intensive care;
* Participating carrier of a defibrillator, a stimulating of the vagus nerve, or quite different surgical high-frequency device.

+Locations (1)

FacilityCityCountryStatus
Institut Du Cerveau Et de La Moelle EpiniereParisFrance

+Investigators

  • quang TRAN, Study director, BioSerenity

My Notes